Thiazolo[3,2-a]pyrimidines are structural analogues of biogenic purine bases, thus may be considered as potential purine antagonists. The synthesis of these heterocyclic systems attracts significant attention from researchers in the field of organic and medicinal chemistry due to their wide range of biological activities, e.g. anti-inflammatory, antimicrobial, antioxidant, antiviral, and anticancer. The high bioactivity of thiazolo[3,2-a]pyrimidine derivatives stimulates the development of fundamentally new synthesis options, which include modern catalytic, microwave and ultrasonic methods for activating cycloaddition reactions, and the improvement of already known methods. This, in turn, became a strong basis for summarizing and systematizing the existing array of literature sources from 2000 to 2024 relating to the methods of obtaining and biomedical profile of thiazolo[3,2-a]pyrimidines and their hydrogenated analogues.

Nanomaterials have attracted a great deal of attention from the scientific community due to their unique properties and applications. The small size metal oxides have opened up the door for intensive research to utilize their properties for biomedical applications. Silver nanoparticle (AgNPs) and metal oxide nanomaterials like MgO, ZnO, NiO and its silver doped nanocomposites (Ag-MgO, Ag-ZnO, Ag-NiO) have been prepared using solid state combustion method using polyvinyl alcohol (PVA) as a fuel. The structure of as prepared oxides and its silver doped nanocomposites were characterized using X-ray diffraction (XRD) tool and morphology by Scanning Electron Micrograph (SEM) tool as well as Transmission electron micrograph tool respectively. Presence of the metals in the oxides and its Ag composite was confirmed by the EDX pattern. Bonding nature in the composite is well studied by the Fourier transform infrared (FT-IR) tool. Antibacterial activity studies of the nanocomposites are carried out against various bacteria.

Fused pyrimidines play an imperative role in our life due to their biological importance in the struggle of microorganisms. A series of 4-aryl-3-methyl-1-phenyl-1,4,6,7-tetrahydropyrazolo[3,4-d] thiazolo[3,2-a]pyrimidine (4a-j) were synthesized by cyclization of 3-methyl-1-phenyl-4-aryl-1,4,5,7-tetrahydro-6H-pyrazolo[3,4-d]pyrimidine-6-thiones (3a-j) with 1,2-dibromoethane in presence of anhydrous potassium carbonate. Earlier, compounds (3a-j) were synthesized by the condensation of 5-methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one (2), different substituted benzaldehyde and thiourea with catalytic amount of con. HCl in methanol. Compound 2 was synthesized by condensation of ethyl acetoacetate (1) and phenylhydrezine in presence of a catalytic amount of acetic acid at reflux temperature. The constitution of the synthesized products has been characterized by using elemental analysis, Infrared, ¹H-NMR spectroscopy and further supported by Mass spectroscopy. All the products have been screened for their in-vitro biological assay like antibacterial and antifungal activity at concentration of 500 μg/ml. It was exposed that most of the compounds displayed inspiring antibacterial and antifungal activity compared to the used reference standard.